Detalhe da pesquisa
1.
Off-label and compassionate use of targeted anticancer therapies: The experience of an Italian pediatric cancer center.
Pediatr Blood Cancer
; 70(3): e30148, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36583462
2.
Immune-mediated cytopenias (IMCs) after HSCT for pediatric non-malignant disorders: epidemiology, risk factors, pathogenesis, and treatment.
Eur J Pediatr
; 182(6): 2471-2483, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967419
3.
Guillain-Barré syndrome after bortezomib therapy in a child with relapsed acute lymphoblastic leukemia.
Pediatr Hematol Oncol
; 39(2): 187-192, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34369835
4.
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia.
Leukemia
; 37(1): 53-60, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36310183
5.
The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Cancers (Basel)
; 16(1)2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201506
6.
Gynecomastia after euthyroidism restoration in a patient with type 1 diabetes and Graves' disease.
Clin Case Rep
; 6(8): 1481-1484, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30147887